World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
44043
World Ranking
5345
National Ranking
2886

Overview

Achim A. Jungbluth is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research contributions primarily span the fields of medicine and biochemistry, genetics, and molecular biology, with a significant focus on oncology, molecular biology, pulmonary and respiratory medicine, immunology, and cancer research.

The scientist's main areas of study include:

  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Cutaneous Melanoma Detection and Management
  • Sarcoma Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Lung Cancer Research Studies
  • Neuroendocrine Tumor Research Advances

Jungbluth has published articles in several noteworthy venues, including:

  • Modern Pathology
  • The American Journal of Surgical Pathology
  • Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Human Pathology

Among the recent papers associated with Jungbluth are the following:

  • SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization (2020), published in Journal of Thoracic Oncology
  • Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies (2020), published in Histopathology
  • Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing (2020), published in Clinical Cancer Research
  • Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors (2020), published in The American Journal of Surgical Pathology
  • Anatomic position determines oncogenic specificity in melanoma (2022), published in Nature

Frequent collaborators with Jungbluth include:

  • Denise Frosina (20 co-authored works)
  • Marc Ladanyi (14 co-authored works)
  • Britta Weigelt (14 co-authored works)
  • Natasha Rekhtman (12 co-authored works)
  • Klaus J. Busam (9 co-authored works)

Best Publications

  • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    Eiichi Sato;Sara H. Olson;Jiyoung Ahn;Brian Bundy

  • Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

    Michael A. Postow;Margaret K. Callahan;Margaret K. Callahan;Christopher A. Barker;Christopher A. Barker;Yoshiya Yamada;Yoshiya Yamada

  • Cancer/testis antigens, gametogenesis and cancer.

    Andrew J. G. Simpson;Otavia L. Caballero;Achim Jungbluth;Yao-Tseng Chen

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.

    Matthew J. Scanlan.;Ali O. Gure.;Achim A. Jungbluth.;Lloyd J. Old.

  • Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

    Naomi N. Hunder;Herschel Wallen;Jianhong Cao;Deborah W. Hendricks

  • Characterization of tumor necrosis factor-deficient mice

    Michael W. Marino;Ashley Dunn;Dianne Grail;Melissa Inglese

  • Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues

    Achim A. Jungbluth;Yao-Tseng Chen;Elisabeth Stockert;Klaus J. Busam

  • CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

    Padmanee Sharma;Yu Shen;Sijin Wen;Sachiko Yamada

  • Integrative Molecular Characterization of Malignant Pleural Mesothelioma

    Julija Hmeljak;Francisco Sanchez-Vega;Katherine A. Hoadley;Juliann Shih

  • Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

    E Jäger;Y Nagata;S Gnjatic;H Wada

  • NY-ESO-1: review of an immunogenic tumor antigen.

    Sacha Gnjatic;Hiroyoshi Nishikawa;Achim A Jungbluth;Ali O Güre

  • Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.

    Ian D. Davis;Weisan Chen;Heather Jackson;Phillip Parente;Phillip Parente

  • NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls

    James P. Solomon;Irina Linkov;Andrea Rosado;Kerry Mullaney

  • CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

    Luiz Gonzaga Almeida;Noboru J. Sakabe;Alice R. deOliveira;Maria Cristina C. Silva

  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial

    Chaitanya R Divgi;Neeta Pandit-Taskar;Achim A Jungbluth;Victor E Reuter

  • CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

    Jianda Yuan;Sacha Gnjatic;Hao Li;Sarah Powel

  • Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.

    Jaclyn F. Hechtman;Ryma Benayed;David M. Hyman;Alexander Drilon

  • Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

    Danila Valmori;Naira E. Souleimanian;Valeria Tosello;Nina Bhardwaj

  • Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

    Jianda Yuan;Matthew Adamow;Brian A. Ginsberg;Teresa S. Rasalan

Frequent Co-Authors

Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Sacha Gnjatic
Sacha Gnjatic Icahn School of Medicine at Mount Sinai
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Klaus J. Busam
Klaus J. Busam Memorial Sloan Kettering Cancer Center
Gerd Ritter
Gerd Ritter Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Elisabeth Stockert
Elisabeth Stockert Memorial Sloan Kettering Cancer Center
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Andrew M. Scott
Andrew M. Scott La Trobe University
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA involves a variety of academic and professional pathways beyond traditional medical school. Many online programs now offer flexible and accelerated options to help students and working professionals reach their goals faster.

For example, students seeking advanced nursing degrees may consider enrolling in the shortest msn to dnp program, which provides a fast track from a Master of Science in Nursing (MSN) to a Doctor of Nursing Practice (DNP). For those looking for affordability, the cheapest dnp program is an excellent option for advancing your qualifications without accumulating significant debt.

If your interest lies in entering the field quickly as a practical nurse, the lpn accelerated program allows you to complete your training in a shorter timeframe than traditional routes. Additionally, aspiring psychiatric mental health nurse practitioners can benefit from the fastest pmhnp program, which offers streamlined coursework for rapid entry into this rewarding specialty.

Exploring these alternative online degrees and career pathways can open doors to new opportunities, greater flexibility, and faster career advancement in the evolving landscape of healthcare in the USA.

Best Scientists Citing Achim A. Jungbluth

Trending Scientists